Peter NAGY, DSc. is the Scientific Director and Head of the Molecular Immunology and Toxicology Department at the National Institute of Oncology, Budapest. The major area of his scientific interest is centered on reprograming of metabolic and cellular signaling pathways in cancer. The primary focus of his research activities lies within redox regulation of protein functions, antioxidant defense mechanisms and alterations of transulfuration pathways. These processes play critical roles in oncogenesis, tumor progression, immune-response/suppression and in the development of resistance to currently applied therapies. Several fundamental discoveries from his lab were advanced in the innovation chain towards drug development activities, which are currently underway in spin-off biotech companies.
